CBL-514 Injection for Subcutaneous Fat
What You Need to Know Before You Apply
What is the purpose of this trial?
A Phase 3b, Multicenter, Two stage, Double-blind, Long term Follow up and Open-label Extension Study of Participants Who have Completed the CBL-0301 or CBL-0302 Study for Reducing Abdominal Subcutaneous Fat (Stage 1)
Who Is on the Research Team?
Anne Sheu
Principal Investigator
Caliway Biopharmaceuticals Co., Ltd.
Are You a Good Fit for This Trial?
This trial is for people who have already completed a previous study (CBL-0301 or CBL-0302) aimed at reducing belly fat. Participants should be generally healthy and willing to continue with follow-up visits.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- CBL-514 Injection
Trial Overview
The study compares injections of CBL-514, a drug designed to reduce under-the-skin fat, against placebo (saltwater solution). It uses a double-blind design followed by an open-label extension for long-term safety and effectiveness.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
No study drug will be administered in Stage 1. Eligible participants who received prior treatment with CBL-514 in the parent studies will be included.
No study drug will be administered in Stage 1. Eligible participants who received prior treatment with Placebo in the parent studies will be included.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Caliway Biopharmaceuticals Co., Ltd.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.